Altogether these studies raise the possibility that VEPH1 may augment signaling networks involved in prostate cancer progression and may be involved in mesenchymal-epithelial cell transitions that can impede metastasis while promoting expansion of lesions formed by metastatic cells. Here, VEPH1 is linked to prostate cancer.